CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT-GSK-3β-Snail SignalsReport as inadecuate

CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT-GSK-3β-Snail Signals - Download this document for free, or read online. Document in PDF available to download.

Oxidative Medicine and Cellular Longevity - Volume 2016 2016, Article ID 5874127, 14 pages -

Research Article

Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, No. 132 Waihuandong Road, University Town, Guangzhou 510006, China

Department of Pharmacology, School of Pharmaceutical Sciences, Jinan University, Guangzhou 510632, China

Received 7 June 2015; Accepted 19 October 2015

Academic Editor: Kota V. Ramana

Copyright © 2016 Lin-Lin Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Some evidence indicated that chemoresistance associates with the acquisition of cancer stem-like properties. Recent studies suggested that chemokines can promote the chemoresistance and stem cell properties in various cancer cells, while the underling mechanism is still not completely illustrated. In our study, we found that CCL21 can upregulate the expression of P-glycoprotein P-gp and stem cell property markers such as Bmi-1, Nanog, and OCT-4 in colorectal cancer CRC HCT116 cells and then improve the cell survival rate and mammosphere formation. Our results suggested that Snail was crucial for CCL21-mediated chemoresistance and cancer stem cell property in CRC cells. Further, we observed that CCL21 treatment increased the protein but not mRNA levels of Snail, which suggested that CCL21 upregulates Snail via posttranscriptional ways. The downstream signals AKT-GSK-3β mediated CCL21 induced the upregulation of Snail due to the fact that CCL21 treatment can obviously phosphorylate both AKT and GSK-3β. The inhibitor of PI3K-Akt, LY294002 significantly abolished CCL21 induced chemoresistance and mammosphere formation of HCT116 cells. Collectively, our results in the present study revealed that CCL21 can facilitate chemoresistance and stem cell property of CRC cells via the upregulation of P-gp, Bmi-1, Nanog, and OCT-4 through AKT-GSK-3β-Snail signals, which suggested a potential therapeutic approach to CRC patients.

Author: Lin-Lin Lu, Xiao-Hui Chen, Ge Zhang, Zong-Cai Liu, Nong Wu, Hao Wang, Yi-Fei Qi, Hong-Sheng Wang, Shao Hui Cai, and Jun D



Related documents